Share this post:

Martijn van de Zande of Nieuws & Co. reports on how Johnson & Johnson sets the right example for other companies to follow. The interview includes a discussion with lung doctor Wiel de Lange from the UMCG hospital on the treatment of multidrug-resistant tuberculosis. Marijn Verhoef, researcher from the Access to Medicine Foundation, discusses the key findings of the AMR Benchmark, which is followed up by health reporter Rinke van de Brink, who reports on the serious threat of resistant bacteria.

Listen Live